Berlin
Germany
44
2026-05-21
The entities that hold a legal rights for patent applications filed by inventor Thede Kai:
Kai Thede from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF TREATING INFLAMMATORY DISEASES
#2 | 2026-04-02METHODS OF TREATING INFLAMMATORY DISEASES
#3 | 2025-11-13IMIDAZO(1,2-1)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS
#4 | 2025-02-27BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER
#5 | 2024-05-30MAP4K1 INHIBITORS
#6 | 2023-07-06P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS
#7 | 2023-06-22PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12
#8 | 2023-04-20PYRAZOLOTRIAZINES
#9 | 2023-04-06IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12
#10 | 2023-01-19ANALOGUES OF 3-(5-METHYL-1,3-THIAZOL-2-YL)-N-{(1R)-1-[2-(TRIFLUORO-METHYL)PYRIMIDIN-5-YL]ETHYL}BENZAMIDE
#11 | 2021-06-244,5-annulated 1,2,4-triazolones
#12 | 2020-06-254-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
#13 | 2020-03-19Macrocyclic indole derivatives
#14 | 2019-12-124,5-annulated 1,2,4-triazolones
#15 | 2018-02-151,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
#16 | 2018-02-15N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS
#17 | 2018-02-013-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
#18 | 2017-04-27INHIBITORS OF THE WNT SIGNALLING PATHWAYS
#19 | 2017-04-20NOVEL COMPOUNDS
#20 | 2016-09-15Compounds
#21 | 2016-08-11SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
#22 | 2016-02-25NOVEL COMPOUNDS
#23 | 2015-05-28Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#24 | 2014-09-18Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
#25 | 2014-01-30(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment
#26 | 2014-01-30Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#27 | 2014-01-09Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
#28 | 2013-02-21Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof
#29 | 2013-02-14CYCLIC KETO-ENOLS FOR THERAPY
#30 | 2012-10-18Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
#31 | 2012-05-24CYCLIC KETOENOLS FOR THERAPY
#32 | 2012-05-17Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#33 | 2012-01-26Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
#34 | 2012-01-26Substituted furancarboxamides, and use thereof
#35 | 2011-08-18SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF
#36 | 2011-07-283-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
#37 | 2011-05-26Substituted (pyrazolylcarbonyl)imidazolidinones and their use
#38 | 2010-12-02Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
#39 | 2010-04-29Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof
#40 | 2010-04-15Substituted dipyridyl-dihydropyrazolones and use thereof
#41 | 2010-01-28BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISEASES
#42 | 2009-07-16Substituted quinolones III
#43 | 2008-10-23Substituted quinolones II
#44 | 2007-12-20Substituted quinolones
91663 ⎘